CAS 号: 137219-37-5 (中文同义词:普利地星)
所有产品仅用于科学研究,不得用于人体或动物实验。
目录号:HD00053
分子式:C57H87N7O15
分子量:1110.34
纯度:≥98%
长期储存条件:Store in a tight container at 2-8℃.
描述:A Repurposed Drug for the Treatment of COVID-19;Antitumor
规格 | 价格 (EXW) | 是否有货 | 数量 | 加入购物车 |
---|---|---|---|---|
1mg | ¥5750.00 | 有货 | - 1 + | |
10mg | ¥11380.00 | 有货 | - 1 + | |
50mg | ¥43050.00 | 有货 | - 1 + | |
100mg | 询价 | 有货 | - 1 + |
[1] Pardanani A, Tefferi A, Guglielmelli P, Bogani C, Bartalucci N, Rodríguez J, Extremera S, Pérez I, Alfaro V, Vannucchi AM. Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial. Blood Cancer J. 2015 Mar 13;5:e286.
[2] Lollo G, Hervella P, Calvo P, Avilés P, Guillén MJ, Garcia-Fuentes M, Alonso MJ, Torres D. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative. Int J Pharm. 2015 Apr 10;483(1-2):212-9.
[3] Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. José F. Varona,et al. doi: https://doi.org/10.1101/2021.05.25.21257505.
您是第 1979212 位访问者
电话:0086-571-89903882
邮箱:hdcsales@huidacollection.cn
Copyright © 2021 浙江珲达生物科技有限公司 浙ICP备20008217-2号 Designed by Wanhu 公安备案号 33010502006723